RPRX icon

Royalty Pharma
RPRX

Overview Fund Activity

450 hedge funds and large institutions have $12.3B invested in Royalty Pharma in 2025 Q2 according to their latest regulatory filings, with 76 funds opening new positions, 170 increasing their positions, 154 reducing their positions, and 62 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
450
Holders Change
+8
Holders Change %
+1.81%
% of All Funds
6.04%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.08%
New
76
Increased
170
Reduced
154
Closed
62
Calls
$81.6M
Puts
$17.9M
Net Calls
+$63.7M
Net Calls Change
+$8.88M

Top Buyers

1
Capital International Investors
1
Capital International Investors
California
$788M
2
Morgan Stanley
2
Morgan Stanley
New York
$1.68B
3
Baillie Gifford & Co
3
Baillie Gifford & Co
United Kingdom
$649M
4
Arrowstreet Capital
4
Arrowstreet Capital
Massachusetts
$107M
5
Amundi
5
Amundi
France
$101M

Top Sellers

1
Viking Global Investors
1
Viking Global Investors
Connecticut
$93.6M
2
Two Sigma Advisers
2
Two Sigma Advisers
New York
$30.5M
3
GC
3
GMT Capital
Georgia
$0
4
Bank of America
4
Bank of America
North Carolina
$73.5M
5
Qube Research & Technologies (QRT)
5
Qube Research & Technologies (QRT)
United Kingdom
$10.7M
Name Holding Trade Value Shares
Change 		Shares
Change %
Morgan Stanley
1
Morgan Stanley
New York
$1.68B +$201M +5,574,271 +14%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$1.45B +$34.4M +953,728 +2%
Vanguard Group
3
Vanguard Group
Pennsylvania
$1.31B -$10.8M -299,770 -0.8%
BlackRock
4
BlackRock
New York
$916M +$31.5M +872,994 +4%
Capital International Investors
5
Capital International Investors
California
$788M +$788M +21,880,620 New
Baillie Gifford & Co
6
Baillie Gifford & Co
United Kingdom
$649M +$166M +4,618,171 +34%
Swedbank
7
Swedbank
Sweden
$438M – – –
State Street
8
State Street
Massachusetts
$367M +$24.5M +678,810 +7%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$299M +$6.48M +177,036 +2%
CIA
10
Caledonia Investments (Australia)
Australia
$232M +$47.9M +1,330,162 +26%
Adage Capital Partners
11
Adage Capital Partners
Massachusetts
$216M -$9.01M -250,000 -4%
Norges Bank
12
Norges Bank
Norway
$181M +$181M +5,034,369 New
Victory Capital Management
13
Victory Capital Management
Texas
$162M +$31.3M +868,546 +24%
UBS AM
14
UBS AM
Illinois
$147M +$44.3M +1,229,065 +43%
Northern Trust
15
Northern Trust
Illinois
$145M +$37.7M +1,045,593 +35%
Charles Schwab
16
Charles Schwab
California
$108M -$4.1M -113,694 -4%
PCM
17
Patient Capital Management
Maryland
$108M +$553K +15,342 +0.5%
Arrowstreet Capital
18
Arrowstreet Capital
Massachusetts
$107M +$58.2M +1,615,706 +119%
NSCM
19
New South Capital Management
Tennessee
$104M -$753K -20,900 -0.7%
Amundi
20
Amundi
France
$101M +$56.5M +1,560,093 +126%
Legal & General Group
21
Legal & General Group
United Kingdom
$98M -$3.31M -91,787 -3%
Viking Global Investors
22
Viking Global Investors
Connecticut
$93.6M -$287M -7,966,479 -75%
JAM
23
Jupiter Asset Management
United Kingdom
$89M +$49.7M +1,380,115 +127%
UBS Group
24
UBS Group
Switzerland
$79.5M +$30.8M +854,289 +63%
Bank of America
25
Bank of America
North Carolina
$73.5M -$71.5M -1,984,239 -49%
1
2 3 4 5